세계의 의약품 단위 용량 포장 시장 보고서(2025년)
Pharmaceutical Unit-Dose Packaging Global Market Report 2025
상품코드 : 1855951
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,700,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,685,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,669,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

의약품 단위 용량 포장 시장 규모는 최근 급속히 확대되고 있습니다. 2024년 487억 8,000만 달러로 평가되었고, 2025년에는 545억 달러에 달하고, CAGR 11.7%로 성장할 전망입니다. 이 역사적인 기간의 성장은 투약 실수 감소에 대한 주력 강화, 중앙 집중식 병원 약국 시스템의 광범위한 채택, 감염 제어 프로토콜에 대한 인식 증가, 의약품 조제 규제의 진화, 선진국의 건강 관리 지출 증가와 관련이 있습니다.

의약품 단위 용량 포장 시장 규모는 향후 수년간 급성장할 것으로 전망됩니다. 2029년에는 CAGR 11.3%로 837억 8,000만 달러로 성장할 전망입니다. 예측 기간 동안 예측되는 성장의 원동력은 세계 건강 관리 인프라 확대, 신흥 시장에서 의약품 생산 증가, 감염 및 생활 습관병의 유행, 재택치료 및 외래 의료에 대한 선호도 증가, 가치 기반 의료 제공으로의 전환 등입니다. 예측 기간 동안의 선진 패키징 동향으로는 스마트 패키징 기술의 혁신, 지속 가능한 기술의 채택, 디지털 헬스 툴의 통합, 소아 및 노인 친화적인 디자인의 발전, 맞춤형 의료 패키징의 진전 등을 들 수 있습니다.

예방 접종 프로그램과 백신 접종 캠페인의 확대는 향후 몇 년간의 의약품 단위 용량 포장 시장의 성장을 지원할 것으로 예측됩니다. 예방 접종 프로그램 및 백신 접종 캠페인은 백신의 체계적인 투여를 통해 감염으로부터 지역 사회를 보호하는 것을 목표로하는 체계적인 공중 보건 활동입니다. 이러한 프로그램이 증가하고 있는 배경에는 감염의 발생 빈도가 증가하고 있을 수 있으며, 정부와 보건기구는 질병의 감염을 방지하고 공중 보건을 보호하기 위한 노력을 강화하고 있습니다. 의약품 단위 용량 포장은 정확한 투여, 투약 실수의 위험 감소, 무균 상태 유지, 대규모 백신 접종 활동에 있어서의 배포·투여 프로세스의 간소화에 의해 이러한 대처를 지원하고 있습니다. 예를 들어, 스위스에 본부를 두는 정부간 기관인 세계보건기구(WHO)는 2023년 12월, COVID-19를 제외한 세계의 백신 접종량이 2021년의 19%에서 2022년에는 24%로 증가했다고 보고하고 있으며, 이는 주로 PCV, MR, Td 함유 백신의 유통 따라서 예방접종 프로그램과 백신접종 캠페인의 규모 확대는 의약품 단위 용량 포장 시장의 성장에 기여하고 있습니다.

의약품 단위 용량 포장 시장의 주요 기업은 투여 정밀도를 향상시키고 의료 현장에서의 업무 효율성을 높이기 위해 무균 단위 도즈 제네릭 의약품 개발에 주력하고 있습니다. 무균 단위 도즈 제네릭 의약품은 미생물 오염이 없는 개별 포장 용량으로 정확한 투여를 위한 안전하고 신뢰할 수 있는 옵션을 제공하는 동시에 브랜드 무균 제품을 대체하는 비용 효율적인 옵션을 제공합니다. 예를 들어, 2023년 8월 미국 제약 회사 Ritedose Pharmaceuticals는 크로몰린 나트륨 흡입액 USP(2ml 당 20mg)를 출시했습니다. 이 제품은 천식의 예방관리에 사용되는 흡입 항염증 치료제로, 1회량 바이알 60개들이로 이번 출시에 리테도스의 흡입 치료 폭이 넓어져, 이 약에 의존하고 있는 의료 제공자나 환자가 안정적으로 입수할 수 있게 되었습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

SHW
영문 목차

영문목차

Pharmaceutical unit-dose packaging is the process of packaging medication doses into individual, pre-measured containers. Its primary goal is to provide accurate dosing, reduce medication errors, and improve patient safety. It also supports drug stability, extends shelf life, and enables easy handling and administration in hospitals, pharmacies, and home care settings.

The main types of pharmaceutical unit-dose packaging include blisters, ampoules, vials, and prefilled syringes and cartridges. Blisters consist of sealed cavities made of plastic or aluminum, each containing a single tablet or capsule. They ensure product protection, accurate dosing, and tamper evidence. Materials used include plastics, glass, paper, paperboard, and metal. Applications include ophthalmic, injectable, biologics, wound care, respiratory therapy, and oral products.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The pharmaceutical unit-dose packaging market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical unit-dose packaging market statistics, including pharmaceutical unit-dose packaging industry global market size, regional shares, competitors with a pharmaceutical unit-dose packaging market share, detailed pharmaceutical unit-dose packaging market segments, market trends, and opportunities, and any further data you may need to thrive in the pharmaceutical unit-dose packaging industry. This pharmaceutical unit-dose packaging market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pharmaceutical unit-dose packaging market size has grown rapidly in recent years. It will grow from $48.78 billion in 2024 to $54.50 billion in 2025 at a compound annual growth rate (CAGR) of 11.7%. The growth during the historic period is linked to a stronger focus on reducing medication errors, wider adoption of centralized hospital pharmacy systems, increased awareness of infection control protocols, evolving pharmaceutical dispensing regulations, and higher healthcare spending in developed countries.

The pharmaceutical unit-dose packaging market size is expected to see rapid growth in the next few years. It will grow to $83.78 billion in 2029 at a compound annual growth rate (CAGR) of 11.3%. The growth projected for the forecast period is driven by expanding global healthcare infrastructure, rising pharmaceutical production in emerging markets, increasing prevalence of infectious and lifestyle-related diseases, growing preference for home-based and outpatient care, and the shift toward value-based healthcare delivery. Key trends during the forecast period include innovations in smart packaging technology, adoption of sustainable practices, integration of digital health tools, developments in child-resistant and senior-friendly designs, and advancements in personalized medicine packaging.

The expansion of immunization programs and vaccination campaigns is expected to support the growth of the pharmaceutical unit-dose packaging market in the coming years. Immunization programs and vaccination campaigns are structured public health efforts aimed at protecting communities from infectious diseases through the systematic administration of vaccines. The growing number of these programs is driven by the increasing frequency of infectious disease outbreaks, leading governments and health organizations to intensify their efforts to prevent disease transmission and safeguard public health. Pharmaceutical unit-dose packaging supports these initiatives by ensuring precise dosing, reducing the risk of medication errors, maintaining sterility, and simplifying the distribution and administration processes during large-scale vaccination activities. For example, in December 2023, the World Health Organization, an intergovernmental organization based in Switzerland, reported that global vaccine volumes, excluding those for COVID-19, increased from nineteen percent in 2021 to twenty-four percent in 2022, largely due to a rise in the distribution of PCV, MR, and Td-containing vaccines. Therefore, the growing scale of immunization programs and vaccination campaigns is contributing to the growth of the pharmaceutical unit-dose packaging market.

Leading companies in the pharmaceutical unit-dose packaging market are focusing on the development of sterile unit-dose generic medications to improve dosing precision and enhance operational efficiency in healthcare settings. Sterile unit-dose generic medications are individually packaged doses that are free from microbial contamination, providing a safe and reliable option for accurate administration while offering a cost-effective alternative to branded sterile products. For instance, in August 2023, Ritedose Pharmaceuticals, a pharmaceutical company based in the United States, introduced a cromolyn sodium inhalation solution, USP (twenty milligrams per two milliliters). This product is an inhaled anti-inflammatory treatment used for the preventive management of asthma and is available in cartons containing sixty single-dose vials. The launch broadens Ritedose's range of inhalation therapies and ensures consistent availability for healthcare providers and patients who rely on this medication.

In November 2024, Safecor Health, a unit-dose repackaging company based in the United States, acquired the domestic unit-dose packaging business of Viatris Inc. for an undisclosed amount. This acquisition is intended to expand Safecor Health's range of generic unit-dose products, increase cost efficiencies, and strengthen its partnerships across the healthcare supply chain. The goal is to deliver more effective solutions to healthcare providers and pharmaceutical manufacturers. Viatris Inc. is a pharmaceutical company located in the United States that offers services related to pharmaceutical unit-dose packaging.

Major players in the pharmaceutical unit-dose packaging market are Pfizer Inc., Johnson & Johnson Innovation LLC, Merck & Co. Inc., AbbVie Inc., Becton Dickinson and Company, Amcor Plc, Nipro Corporation, Aptar Group Inc., West Pharmaceutical Services Inc., Constantia Flexibles Group GmbH, Klockner Pentaplast, Stevanato Group S.p.A., SGD SA, SP Group, Jones Healthcare Group, Innovative Pharmacy Packaging Corporation Inc., Medical Packaging Inc. LLC, Adelphi Healthcare Packaging, Sonic Packaging Industries, Alfipa, Unit Pack Company Inc.

North America was the largest region in the pharmaceutical unit-dose packaging market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pharmaceutical unit-dose packaging report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the pharmaceutical unit-dose packaging market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pharmaceutical unit-dose packaging market consists of sales of products such as unit-dose pouches, sachets, strip packs, stick packs, prefilled droppers, nasal spray units, and ophthalmic single-dose containers. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmaceutical Unit-Dose Packaging Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharmaceutical unit-dose packaging market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for pharmaceutical unit-dose packaging ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pharmaceutical unit-dose packaging market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Pharmaceutical Unit-Dose Packaging Market Characteristics

3. Pharmaceutical Unit-Dose Packaging Market Trends And Strategies

4. Pharmaceutical Unit-Dose Packaging Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Pharmaceutical Unit-Dose Packaging Growth Analysis And Strategic Analysis Framework

6. Pharmaceutical Unit-Dose Packaging Market Segmentation

7. Pharmaceutical Unit-Dose Packaging Market Regional And Country Analysis

8. Asia-Pacific Pharmaceutical Unit-Dose Packaging Market

9. China Pharmaceutical Unit-Dose Packaging Market

10. India Pharmaceutical Unit-Dose Packaging Market

11. Japan Pharmaceutical Unit-Dose Packaging Market

12. Australia Pharmaceutical Unit-Dose Packaging Market

13. Indonesia Pharmaceutical Unit-Dose Packaging Market

14. South Korea Pharmaceutical Unit-Dose Packaging Market

15. Western Europe Pharmaceutical Unit-Dose Packaging Market

16. UK Pharmaceutical Unit-Dose Packaging Market

17. Germany Pharmaceutical Unit-Dose Packaging Market

18. France Pharmaceutical Unit-Dose Packaging Market

19. Italy Pharmaceutical Unit-Dose Packaging Market

20. Spain Pharmaceutical Unit-Dose Packaging Market

21. Eastern Europe Pharmaceutical Unit-Dose Packaging Market

22. Russia Pharmaceutical Unit-Dose Packaging Market

23. North America Pharmaceutical Unit-Dose Packaging Market

24. USA Pharmaceutical Unit-Dose Packaging Market

25. Canada Pharmaceutical Unit-Dose Packaging Market

26. South America Pharmaceutical Unit-Dose Packaging Market

27. Brazil Pharmaceutical Unit-Dose Packaging Market

28. Middle East Pharmaceutical Unit-Dose Packaging Market

29. Africa Pharmaceutical Unit-Dose Packaging Market

30. Pharmaceutical Unit-Dose Packaging Market Competitive Landscape And Company Profiles

31. Pharmaceutical Unit-Dose Packaging Market Other Major And Innovative Companies

32. Global Pharmaceutical Unit-Dose Packaging Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pharmaceutical Unit-Dose Packaging Market

34. Recent Developments In The Pharmaceutical Unit-Dose Packaging Market

35. Pharmaceutical Unit-Dose Packaging Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기